HSPA5 and neoplasm: However, the study of ERS-related multidrug resistant tumors still faces serious challenges, such as how GRP78 senses and measures protein metabolic stress and whether a specific choice should be selected from the three pathways when GRP78 in tumor cells faces the complex TME and generates ERS.